Kim Chase

United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD.

Bourdon Associates, Inc. performs financial and accounting services. The firm specializes in accounting and finance consulting, part time finance staff, outsourced controllers and senior accountants, interim staffing for senior finance roles, nonprofit and endowment accounting, audit preparation, and financial systems implementation. The company was founded by Jim Bourdon in 1998 and is headquartered in Waltham, MA.

The Abt Bio-Pharma Solutions team has provided integrated strategic, research, and communications services to the pharmaceutical, biotechnology, medical device, and diagnostics industries for 25 years. Its parent company, Abt Associates Inc., is one of the largest research and consulting firms in the world, applying scientific expertise to a wide range of health, economic, social, environmental, and technological policy issues. Founded in 1965, Abt Associates has annual revenue in excess of $200 million and a staff of more than 1,000, including national and international experts who are recognized for their knowledge, innovative research techniques, and insightful analysis & recommendations. In the early 1980s, Abt Associates' staff of bio statisticians, clinicians, health economists, and strategic consultants began designing, analyzing, and reporting on clinical trials for a broad variety of drugs and devices covering many therapeutic areas. Over the next decade, their services for commercial sponsors grew to include registries and other real world studies designed to evaluate safety, efficacy, economic, patient compliance, and health-related quality-of-life factors. The Abt Associates Clinical Trials (AACT) division was created in 1997, combining capabilities in bio-statistics, data management, epidemiology, and clinical trials management. To help sponsors demonstrate product value in a competitive global marketplace, their Health Economic Research and Quality of Life Evaluation Services (HERQuLES) team was established and became a leader in collecting & analyzing data on the use of healthcare products & services and on their clinical, economic, quality of life, and satisfaction outcomes. In recent years, AACT expanded capabilities to include pricing & reimbursement & marketing consulting and research services, employing a cross-functional matrixed approach ideally suited for their clients' multifaceted needs. In April 2008, AACT was renamed Abt Bio-Pharma Solutions and established as a wholly owned subsidiary of Abt Associates. Their new name reflects the full range of custom services they provide to sponsors globally. The ABS team continues Abt Associates' 40-year history of commitment to providing knowledge, delivering insight, and improving world health.

BBVA Research USA is the US investment research arm of Banco Bilbao Vizcaya Argentaria SA. The firm is located in Houston, Texas. BBVA Research USA focuses on analysis of the US economy and Federal Reserve monetary policy. In macroeconomic analysis, the team creates models and forecasts for growth, inflation and monetary policy. They pay special attention to the regional outlook and sector analysis, including the real estate market, the financial system and its regulation. Noteworthy publications include FED Watch, which follows Federal Reserve policy, and 'US Economic Watch', which provides in-depth analysis on a number of economic subjects. BBVA Research USA analyzes themes such as credit, unemployment, public finances and local economies, with special emphasis on the Sunbelt states where BBVA has operations.